Source:http://linkedlifedata.com/resource/pubmed/id/15328150
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
2004-12-6
|
pubmed:abstractText |
Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene on the X-chromosome that result in skeletal and cardiac muscle damage and premature death. Studies in mice, including the mdx mouse model of DMD, have demonstrated that circulating bone marrow-derived cells can participate in skeletal muscle regeneration, but the potential clinical utility of treating human DMD by allogeneic marrow transplantation from a healthy donor remains unknown. To assess whether allogeneic hematopoietic cell transplantation (HCT) provides clinically relevant levels of donor muscle cell contribution in dogs with canine X-linked muscular dystrophy (c-xmd), 7 xmd dogs were given hematopoietic cell (HC) transplants from nonaffected littermates. Compared with the pretransplantation baseline, the number of dystrophin-positive fibers and the amount of wild-type dystrophin RNA did not increase after HCT, with observation periods ranging from 28 to 417 days. Similar results were obtained when the recipient dogs were given granulocyte colony-stimulating factor (G-CSF) after their initial transplantation to mobilize the cells. Despite successful allogeneic HCT and a permissive environment for donor muscle engraftment, there was no detectable contribution of bone marrow-derived cells to either skeletal muscle or muscle precursor cells assayed by clonal analyses at a level of sensitivity that should detect as little as 0.1% donor contribution.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0006-4971
|
pubmed:author |
pubmed-author:BoganJanetJ,
pubmed-author:CooperBarry JBJ,
pubmed-author:Dell'AgnolaChiaraC,
pubmed-author:GisburneSerinaS,
pubmed-author:GooleyTheodore ATA,
pubmed-author:HauschkaStephen DSD,
pubmed-author:KornegayJoe NJN,
pubmed-author:KuhrChristian SCS,
pubmed-author:LeeRichard SRS,
pubmed-author:LittleMarie-TérèseMT,
pubmed-author:SaleGeorge EGE,
pubmed-author:StorbRainerR,
pubmed-author:TapscottStephen JSJ,
pubmed-author:WangZejingZ,
pubmed-author:ZellmerEustaciaE
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4311-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15328150-Animals,
pubmed-meshheading:15328150-Disease Models, Animal,
pubmed-meshheading:15328150-Dogs,
pubmed-meshheading:15328150-Dystrophin,
pubmed-meshheading:15328150-Female,
pubmed-meshheading:15328150-Gene Expression Regulation,
pubmed-meshheading:15328150-Immunosuppression,
pubmed-meshheading:15328150-Muscle, Skeletal,
pubmed-meshheading:15328150-Muscular Dystrophy, Animal,
pubmed-meshheading:15328150-Stem Cell Transplantation,
pubmed-meshheading:15328150-Transplantation, Homologous,
pubmed-meshheading:15328150-Whole-Body Irradiation
|
pubmed:year |
2004
|
pubmed:articleTitle |
Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs.
|
pubmed:affiliation |
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, PO Box 19024, Seattle, WA 98109-1024, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|